Effects of a 12-wk whole-body vibration based intervention to improve type 2 diabetes

Maturitas. 2014 Jan;77(1):52-8. doi: 10.1016/j.maturitas.2013.09.005. Epub 2013 Sep 18.

Abstract

Objective: To test the feasibility, safety and effectiveness of a 12-wk whole body vibration (WBV) intervention on glycemic control, lipid-related cardiovascular risk factors and functional capacity among type 2 diabetes mellitus (T2DM) patients in a primary care context.

Methods: Fifty non-insulin dependent T2DM patients were randomized 1:1 to an intervention group that, in addition to standard care, received a 12-wk WBV intervention, and a control group receiving only standard care (from February 2012 through May 2012). Outcomes, including glycated hemoglobin (HbA1c), fasting blood glucose, lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides, lipoproteins, LDL/HDL and atherogenic index) and functional capacity were measured at baseline and after the 12-wk intervention.

Results: After intervention, there was a reduction in HbA1c and fasting blood glucose when compared to the control group, with a mean difference in change scores between groups of -0.55% (95% CI -0.15 to -0.76) and -33.95 mm/dl (95% CI -51.38 to -3.47), respectively. Similarly, most lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides and atherogenic index) were also reduced (p<0.05).

Conclusion: A 12-wk WBV intervention in a primary care context is feasible, safe and effective in improving glycemic profile, lipid-related cardiovascular risk factors and functional capacity among T2DM patients.

Trial number: ACTRN12613000021774.

Keywords: Diabetic patients; Exercise therapy; Glycemic control; Prevention therapy; Vibration therapy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Atherosclerosis / etiology
  • Atherosclerosis / prevention & control
  • Blood Glucose / metabolism*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / therapy*
  • Female
  • Glycated Hemoglobin A / metabolism*
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • Physical Therapy Modalities*
  • Risk Factors
  • Vibration*

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Lipids

Supplementary concepts

  • Diabetes Mellitus, Noninsulin-Dependent, 2